InVivoMAb anti-human CD19

Three-fold higher frequency of circulating chronic lymphocytic leukemia-like B-cell clones in patients with Ph-Myeloproliferative neoplasms. Miltiades P et al., 2015 Aug 14, Leuk Res

Multiplex Genome-Edited T-cell Manufacturing Platform for Off-the-Shelf Adoptive T-cell Immunotherapies. Poirot L et al., 2015 Sep 15, Cancer Res

Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma. Smeltzer JP et al., 2014 Jun 1, Clin Cancer Res

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. Grada Z et al., 2013 Jul 9, Mol Ther Nucleic Acids

Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Horton HM et al., 2008 Oct 1, Cancer Res

Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Rosa D et al., 2005 Dec 20, Proc Natl Acad Sci U S A

A unique human B lymphocyte antigen defined by a monoclonal antibody. Meeker TC et al., 1984 Winter, Hybridoma